BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22791392)

  • 1. Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma.
    Sun X; Li J; Sica G; Fan SQ; Wang Y; Chen Z; Muller S; Chen ZG; Fu X; Dong XY; Guo P; Shin DM; Dong JT
    Head Neck; 2013 Jul; 35(7):1007-14. PubMed ID: 22791392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression.
    Kawaguchi M; Hara N; Bilim V; Koike H; Suzuki M; Kim TS; Gao N; Dong Y; Zhang S; Fujinawa Y; Yamamoto O; Ito H; Tomita Y; Naruse Y; Sakamaki A; Ishii Y; Tsuneyama K; Inoue M; Itoh J; Yasuda M; Sakata N; Jung CG; Kanazawa S; Akatsu H; Minato H; Nojima T; Asai K; Miura Y
    BMC Cancer; 2016 Oct; 16(1):805. PubMed ID: 27756245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
    Li XH; Kikuchi K; Zheng Y; Noguchi A; Takahashi H; Nishida T; Masuda S; Yang XH; Takano Y
    Oral Oncol; 2011 Mar; 47(3):217-23. PubMed ID: 21310648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC).
    Li X; Zhang Q; Zhang M; Luo Y; Fu Y
    Histol Histopathol; 2020 Jul; 35(7):681-690. PubMed ID: 31886514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
    Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
    Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear entrapment of p33ING1b by inhibition of exportin-1: A trigger of apoptosis in head and neck squamous cell cancer.
    Özdaş S
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):66-72. PubMed ID: 29729696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
    Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion.
    Rossa C; Sommer G; Spolidorio LC; Rosenzweig SA; Watson DK; Kirkwood KL
    PLoS One; 2012; 7(9):e45197. PubMed ID: 23028842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic expression of p33ING1b is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
    Li XH; Noguchi A; Nishida T; Takahashi H; Zheng Y; Yang XH; Masuda S; Kikuchi K; Takano Y
    Histol Histopathol; 2011 May; 26(5):597-607. PubMed ID: 21432775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer.
    Mori Y; Kataoka H; Miura Y; Kawaguchi M; Kubota E; Ogasawara N; Oshima T; Tanida S; Sasaki M; Ohara H; Mizoshita T; Tatematsu M; Asai K; Joh T
    Int J Cancer; 2007 Jul; 121(2):241-7. PubMed ID: 17330845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas.
    Gandini NA; Fermento ME; Salomón DG; Blasco J; Patel V; Gutkind JS; Molinolo AA; Facchinetti MM; Curino AC
    Exp Mol Pathol; 2012 Oct; 93(2):237-45. PubMed ID: 22580187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
    Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
    Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
    Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
    Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma.
    Li X; Nishida T; Noguchi A; Zheng Y; Takahashi H; Yang X; Masuda S; Takano Y
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1573-83. PubMed ID: 20182888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear translocation of ATBF1 is a potential prognostic marker for skin cancer.
    Nishio E; Miura Y; Kawaguchi M; Morita A
    Acta Dermatovenerol Croat; 2012; 20(4):239-45. PubMed ID: 23317484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinoma.
    Nagelkerke A; Sweep FC; Stegeman H; Grénman R; Kaanders JH; Bussink J; Span PN
    Head Neck; 2015 Jun; 37(6):896-905. PubMed ID: 24634103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
    Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
    J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.